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Background: Total hip arthroplasty (THA) is an increasingly common treatment for older patients with hip
osteoarthritis. The best strategy for a physiotherapy intervention for older people after THA is not clear in the
literature. The purpose of this protocol study is to test the feasibility of undertaking a full trial clinical to evaluate
the effect of ergometer cycling-associated conventional exercises on functional results and health-related quality of
life (HRQOL) of older patients with THA.
Methods/Design: This study protocol is a prospective, single center, randomized controlled pilot clinical trial. Older
patients (≥60 years) in the postoperative phase after primary unilateral THA for hip osteoarthritis will be consecutively
recruited for this study and randomly allocated to 2 treatment groups. Group I will perform cycle ergometer and
conventional exercises, and group II will perform only conventional exercises. The sessions will be conducted twice a
week for 8 weeks. Assessments will be made at baseline (2 weeks postoperatively: the moment that the patients receive
a referral for physical therapy, which will start after suture removal), after intervention (10 weeks postoperatively), and at
6 months of follow-up (24 weeks postoperatively). The primary outcomes are the function, evaluated using the Harris
Hip Score (HHS) and the Short Physical Performance Battery (SPPB). The secondary outcome is HRQOL, measured using
2 evaluation instruments: the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) and the Western
Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Data collectors will be blinded and will not
have contact with participants during the interventions.
Discussion: This randomized controlled trial will provide evidence regarding the effect of this exercise therapy on
physical function and quality of life in older patients after THA. If our hypothesis is correct, both interventions will be
effective, but the exercises on the cycle ergometer conferring better results in function, physical performance and
quality of life. The study follows Consolidated Standards of Reporting Trials (CONSORT) guidelines, and the approval of
the local ethics committee has been obtained.
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Total hip arthroplasty (THA) is one of the most fre-
quently performed orthopedic surgeries. Its benefits have
been widely documented; in particular, improvements in
pain and function in patients with severe hip osteoarth-
ritis (OA) [1-3]. With the worldwide phenomenon of a
growing older population, this surgical procedure is be-
ing performed more frequently and has consequently in-
creased the number of older patients in rehabilitation
[4]. In this context, it becomes necessary to know how
this profile of patients responds to the various resources
available for rehabilitation in the postoperative period,
since the best strategy for a physiotherapy intervention
is not clear in the literature [5,6].
After THA, deficits in muscle strength and the limita-
tions on physical function, developed during the evolu-
tion of OA, may still be present for many months [7].
Functional deficits in older patients with THA deserve
greater attention because they can significantly influence
quality of life [8]. The objective of rehabilitation is
guided by the early restoration of functional capacity,
and this age group, with the physical changes of aging it-
self, requires a longer time to achieve the desired func-
tional levels [9]. Furthermore, the rehabilitation process
also includes the prevention, minimization, and restor-
ation of possible psychological, emotional, and social im-
pacts arising from, and concomitant with, the functional
deficits of these patients.
Clinical trials have been proposed to investigate differ-
ent strategies of rehabilitation after THA [6]. However,
few have been conducted exclusively with older patients
who have specific physical, psychological, and social
characteristics.
Reduced pain and stiffness and increased function have
been demonstrated in older patients who received hydro-
therapy after THA [10]. The effect of muscle electrical
stimulation on quadriceps and triceps surae muscles was
investigated in another study of older patients with THA.
The addition of this resource to conventional exercise was
effective in the recovery of muscle strength of the knee ex-
tensors and functional independence of these patients
[11]. The inclusion of the ergometer arm in a conventional
exercise program also improved pain, stiffness, and func-
tion in older patients undergoing THA [12].
In a study by Liebs et al. [13], a group of adult and
older patients with THA performed cycle ergometer ex-
ercises in addition to conventional exercises in the early
postoperative period and experienced significant im-
provements in health-related quality of life (HRQOL)
and satisfaction with results of surgery. However, more
information is needed to determine the effect of this re-
source, which is available in most rehabilitation centers,
on functional outcomes and quality of life in older pa-
tients with THA.Objectives and hypotheses
The aims of this prospective, single center, randomized
controlled pilot study are:
 to test the feasibility of undertaking a full trial
clinical;
 to identify if the cycle ergometer will be well
tolerated by older patients with THA in the early
phase of rehabilitation;
 to test the feasibility of the proposed outcome
measures;
 to identify effect size at end of treatment in order to
calculate an appropriate sample size for the full trial
clinical.
Methods/Design
Study design
The study is a prospective, parallel-group, single center,
randomized pilot study conducted in accordance with
Consolidated Standards of Reporting Trials (CONSORT)
guidelines [14].
Participants and recruitment procedures
Patients aged 60 years and older who undergo THA at the
Clinical Hospital of the State University of Campinas,
Brazil, and are recommended to participate in rehabilita-
tion in the physical therapy and occupational therapy ser-
vice of that institution will be consecutively recruited for
this study. Inclusion and exclusion criteria are listed in
Table 1.
Initial contact will occur after the surgery and before
discharge, when information about the study will be pro-
vided to patients. At that time, eligible patients will be
identified and invited to participate, and will receive ver-
bal and written information about the trial (background,
procedure, and randomization). The patients will receive
a consent form and a referral for physical therapy, which
will start after suture removal (2 weeks postoperatively).
After obtaining informed consent from each participant
the baseline information will be collected at the time of
the first physical therapy session. After the intervention
(10 weeks postoperatively) and at 6-month follow-up
after the surgery (24 weeks postoperatively) the patients
will be assessed and the analysis outcomes will be
performed.
A flow diagram of the trial’s progression (recruitment,
randomization, intervention allocation, follow-up, and
data analysis) is shown in Figure 1.
Randomization and allocation concealment
A randomization sequence will be created using a
computer-generated list of random numbers in block
sizes of two. The randomization will be computer gener-
ated using Proc Plan, SAS® software Version 9.1.3 (SAS
Table 1 Inclusion and exclusion criteria for participation in the study
Inclusion criteria Exclusion criteria
Sixty years old and older Hip fracture
Diagnosis of osteoarthritis Postoperative complications: dislocation, infection, cardiovascular
Primary unilateral total hip replacement Revision arthroplasty
No physical therapy performed within 2 months prior to surgery Neuromuscular disease that compromises motor function
Unable to attend the physical therapy sessions at the study institution
Refusal to participate
Figure 1 Flow diagram of the randomized clinical trial.
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Figure 2 Photograph of the cycle ergometer.
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to one of two interventions: cycle ergometer and con-
ventional exercises (group I) or conventional exercises
alone (group II). All participants will have the same
probability of inclusion in either group. The allocation
sequence will be concealed in sequentially numbered
opaque, sealed envelopes. The envelopes with the ran-
dom sequence will be in the possession of a person not
involved in the trial. Envelopes will be opened only after
the enrolled patients have completed all baseline
assessments.
Blinding
Because of the nature of the interventions, patients and
intervention applicator (principal investigator) will not
be blinded. However, there will be blinding of data col-
lectors responsible for baseline and follow-up assess-
ments, and these physiotherapists will be trained to
apply the assessment tools used to collect data for statis-
tical analysis and interpretation of outcomes. For blind-
ing to be maintained the data collectors will not have
contact with participants during the intervention and
the follow-up. The contact is only at the time of evalu-
ation outcomes measures. The physiotherapy sessions
will be conducted individually, in schedules that do not
coincide with the presence of the physiotherapist data
collector or other participant.
Interventions
All subjects will receive the same clinical and orthopedic
care during hospitalization; that is guidelines for posi-
tioning in bed, transfers, limitations of range of motion
(ROM) (hip flexion ≤ 90 degrees and hip adduction only
to midline) and adaptations in the home (raising the
heights of the toilet, bed, sofa, and chairs if necessary).
All subjects will receive a conventional-exercises pro-
gram. Conventional-exercise sessions will last 50 minutes
and be performed 2 days a week for 8 weeks. At the end
of the intervention, patients will have performed 16 ses-
sions and will be 10 weeks postoperative.
Under the guidance of a physical therapist, group I
will perform cycle ergometer exercises on a vertical,
stationary cycle ergometer, Dyamond line, Uniforce Fit-
ness, Dy, model EB 497E (contato@uniforcefitness.com.
br) (Figure 2) and conventional exercises and group II
will perform conventional exercises alone. Ergometer
resistance will be minimal (30 W) because the aim is
not to perform cardiac exercise. The duration of erg-
ometer cycling will be increased gradually, starting with
10 minutes in the first 2 sessions and increasing to
20 minutes for the remainder, and its aims are to im-
prove coordination, proprioception, ROM, and muscle
strength. For this reason, changes are not made during
performance of the exercise; frequency is maintained at60 revolutions per minute and the resistance is also
maintained at the starting level. The height of the sad-
dle will be set so that the forefoot will reach the pedal
with the knee in minimum flexion (5 to 10 degrees).
Special attention will be given to monitoring heart rate
and blood pressure before, during, and after exercise.
Patients will be instructed to follow the exercises on
the cycle ergometer under the supervision of a physio-
therapist, ensuring the execution of this only in the
presence of the professional.
Conventional exercises will consist of exercises to im-
prove joint ROM, muscle strength, function, balance, co-
ordination and gait. A description of conventional
exercises is provided in Table 2.
Intervention and follow-up periods
Assessments will be made at baseline (2 weeks postoper-
atively), after intervention (10 weeks postoperatively)
and at 6-month follow-up (24 weeks postoperatively),
and both treatment groups will have completed the
intervention after 10 weeks. After the 10 weeks of
Table 2 Description of conventional exercises used in total hip arthroplasty rehabilitation
Weeks
postoperative
Lower-limb weight-bearing/
Assistive device for walking
Description
2 to 4 Partial/Walker • Stretching (30 seconds each muscle group): hip flexors, extensors, adductors;
knee flexors, extensors; ankle dorsiflexors and plantar flexors
• Active assisted range of motion (5 to 10 repetitions): hip flexion, extension,
abduction, external rotation; knee flexion, extension
• Muscle strengthening (1 to 3 sets of 10 to 15 repetitions):
o Hip flexors, extensors, abductors (low-resistance rubber band fixed to the ankle
in standing position)
o Knee extensors (sandbag fixed to the ankle in a seated position)
• Transfer training: supine to side - lying in bed; sit and stand bed and chair
• Gait training using a parallel bar and assistive device
4 to 6 Total/Crutch or cane • Stretching maintained
• Active range of motion (5 to10 repetitions): hip flexion, extension, abduction,
external rotation; knee flexion, extension
• Muscle strengthening (1 to 3 sets of 10 to 15 repetitions):
o hip flexors (moderate-resistance rubber band fixed to the ankle in standing
position)
o hip abductors (standing position and seated position with moderate-resistance
rubber band)
o hip extensors (bridge exercise, one- and two-footed in supine position)
o knee extensors and flexors (weight-training equipment, in a seated position, 20% 1RM)
• Balance and gait training: walking on an unstable surface, backward walking, side
step with the use of parallel bars if necessary
6 to 8 Total/With or without cane • Stretching maintained
• Muscle strengthening (1 to 3 sets of 10 to 15 repetitions):
o hip flexors and abductors maintained
o hip extensors (bridge exercise, one- and two-footed in supine position with ball)
• Climbing and descending stairs
• Coordination, balance, and gait training: circuits with stairs, obstacles, changing
direction, changing speed
8 to 10 Total • All exercises maintained
• Addition of the muscle strengthening of hip and knee extensors with squat exercises
(1 to 3 sets of 10 to 15 repetitions)
RM, repetition maximum.
Description of conventional exercises used in total hip arthroplasty rehabilitation.
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form some exercises unsupervised at home. In the
period between the end of supervised intervention and
the final evaluation (at 24 weeks), patients will be able to
telephone the physiotherapist for assistance, and there
will be a phone contact in the 18th week postoperatively
to assess the patients' health condition.
Outcome measures
At baseline, an instrument for sociodemographic and clin-
ical characterization will be used to obtain data regarding
age, sex, race, marital status, education, weight, height, body
mass index, comorbidities, medications, joint pain, and life-
style. Data regarding THA surgery outcome, the primary
clinical outcome, will be the mean change in the hipfunction and physical performance of the lower limbs. The
instruments used will be: Harris Hip Score (HHS) [15] and
the Short Physical Performance Battery (SPPB) [16]. The
mean change in total score in these instruments between
the 2 arms, as measured at baseline, 10 and postoperative
weeks postoperative will be the primary outcome measure.
We will also collect: reason for surgery, waiting time to per-
form the surgery prosthesis fixation, affected side, hospital
stay, postoperative complications, availability of a caregiver
after surgery, adaptations at home, and satisfaction with the
results of surgery and rehabilitation.
Primary outcome measures
The feasibility outcome will include an evaluation of eli-
gibility, recruitment and retention rates (in line with
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completion of outcome measures and assessments. The
primary clinical outcome will be the mean change in the
hip function and physical performance of the lower
limbs. The instruments used will be: the HHS [15] and
the SPPB [16]. The mean change in total score in these
instruments between the 2 arms, as measured at base-
line, 10 and 24 postoperative weeks will be the primary
outcome measure.
The HHS questionnaire, an instrument that was devel-
oped to evaluate the results of THA, has been validated
abroad [17] and in Brazil [18]. It consists of a scale ranging
from 0 to 100 points in 4 domains: pain, function, deform-
ity, and ROM. The maximum scores are 44 points for the
pain domain and 47 for the functional domain, the latter
being subdivided into activities of daily living (14 points)
and gait (33 points). Domains are scored based on subjects’
responses obtained through interviews, with the exception
of the deformity and ROM domains, which are evaluated
by the examiner with the use of a tape measure and goni-
ometer. The deformity domain can be scored from 0 to 4
and the ROM domain from 0 to 5, with higher scores indi-
cating greater ROM, but within of limits for prosthesis, and
less deformity. It is considered a poor functional outcome if
the HHS total score is less than 70 points, fair if the score
is between 70 and 79; good if the score is between 80 and
89, and excellent for 90 to 100 points [15,18].
The SPPB comprises tasks that assess balance, gait
speed, and lower-limb strength in older people. It was de-
veloped in 1994 by Guralnik et al., with support from the
National Institute on Aging, for the Established Popula-
tions for Epidemiologic Studies of the Elderly project in
the US [16]. It is an effective tool for evaluating the phys-
ical performance of the lower limbs in the older popula-
tion and consists of three tests that evaluate, in sequence,
static standing balance; gait speed at a normal pace; and,
indirectly, muscle strength in the lower limbs through the
motion of getting up from a chair and sitting down again
five consecutive times without the aid of the upper limbs.
Each test is scored on a scale ranging from 0 (poor per-
formance) to 4 points (optimal performance). The SPPB
total score is obtained by adding the scores for each test
and ranges from 0 (poor performance) to 12 points (best
performance) [16,19]. The results may be interpreted as
inability or very poor performance (0 to 3 points), low per-
formance (4 to 6 points), moderate performance (7 to 9
points) and high performance (10 to 12 points) [20-22].
Secondary outcome measures
HRQOL will be considered a secondary outcome and the
questionnaires used to assess this will be the Medical Out-
comes Study 36-Item Short-Form Health Survey (SF-36)
[23] as a generic instrument and the Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC)[24] as a specific instrument (measured at the same time
points).
The SF-36 is a generic tool for assessing HRQOL that
has been translated and validated in Brazil [25]. It con-
sists of 36 items comprising 8 categories: functional cap-
acity (10 items), physical aspects (4 items), pain (2
items), general health status (5 items), vitality (4 items),
social aspects (2 items), mental health (5 items) and a
question comparing current health conditions with those
from a year ago. Each question is assigned a score and
the scores tabulated and normalized to a scale of 0 to
100, where 0 corresponds to worst health status and 100
to best health status. There are no cutoff points, and
each category is evaluated separately [23,25].
The WOMAC is a specific instrument that measures
quality of life in patients with OA of the hip and knee
[24]. Its use is indicated for postoperative evaluation of
total arthroplasty of the knee (TKA) or hip [26]. The
questionnaire was originally intended to be self-
administered; however, it has been used for telephone in-
terviews, and recently a computer touch-screen version
has been validated. It comprises 24 items divided into 3
categories. The pain category has five questions, the joint
stiffness category two questions, and the physical disability
category seventeen questions. Each question has five pos-
sible answers using a Likert scale representing difficulty,
and the responses none or never, mild or monthly, moder-
ate or weekly, severe or daily, and extreme or always cor-
respond to scores of 0, 1, 2, 3 and 4, respectively. Thus, 0
represents the absence of the symptom and 4 the worst
manifestation of that symptom. Summing the scores, each
category receives a score that is normalized to a scale of 0
to 100 points, with 0 representing the best health status
and 100 the worst possible status [24,27].
Feasibility outcomes
The feasibility outcome will include an evaluation of eli-
gibility, recruitment and retention rates (in line with
CONSORT recommendations), as well as monitoring of
completion of outcome measures and assessments. Re-
fusal, withdrawal and dropout from the study protocol
will be recorded. Acceptability of the intervention using
the cycle ergometer will be assessed by measuring the
time to fully perform the exercise and by structured
questionnaires with research participants on completion
of the intervention. The feasibility of data collection
strategies will be assessed descriptively and through item
response rates and physical tests.
Statistical analysis
To describe the sample profile descriptive statistics of
numerical variables (scores of scales) will be made.
To compare numerical variables between the two
groups at baseline we will use the Mann-Whitney test,
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pare longitudinal measures between groups and times
we will use analysis of variance (ANOVA) for repeated
measures, followed by Tukey’s multiple comparison test
to compare the groups at all times, and the profile test
contrasts to analyze the evolution between assessments
in each group. The variables will be transformed into
posts (ranks) in the absence of normal distribution.
To estimate the sample size and the power of the sam-
ple we will use the sample size calculation for longitu-
dinal studies with repeated measures to compare
variables between the two groups (I and II) over the two
collection times (pre and post intervention). The signifi-
cance level will be defined (alpha or Type I error) at 5%,
calculating the effect size or delta, which is the expected
difference or difference obtained between the group
means divided by the standard deviation, and the coeffi-
cient of intraclass correlation between repeated mea-
surements. The values of the effect size delta (delta
effect size) will vary generally between 0 and 3. Delta
values of 0.25, 0.75 and 1.25 respectively correspond to
small, medium or large effects. Subsequently, the power
of the sample and the sample size will be obtained by
setting the power at 80% or Type II error (1-beta) at
20%. The significance level for statistical tests will be 5%
(P < 0.05).
Statistical analysis of the data will be performed using
SAS® software, Version 9.1.3 for Windows (SAS Institute
Inc., Cary, NC, USA).
Ethics
The trial complies with the Declaration of Helsinki, and
approval has been granted by the Ethics Committee of
the Medical Sciences Faculty of the State University of
Campinas: approval number 403/2011. The trial is regis-
tered at ClinicalTrials.gov (NCT01622465).
Discussion
The cycle ergometer has been studied as a resource in the
rehabilitation of patients with THA and TKA, but with a
sample composed of both adults and older people. Ac-
cording to two systematic reviews on the topic, no clinical
trials were found that investigated the effect of cycle
ergometer-associated exercises with conventional exer-
cises in a group composed exclusively of older patients in
the postoperative period after THA [5,6].
When proposing exercise therapies for rehabilitation
after THA, it should be considered that the aging process
itself brings significant biological, psychological, and social
decline. Decreased muscle strength and, depending on
other health conditions, serious functional decline can
occur [28]. Hip OA can also result in muscle imbalance,
pain, and stiffness, which may further compromise func-
tion in older patients [29]. Accompanying these physicallosses may be impacts on their psychological, emotional,
and social aspects of quality of life [30,31].
In patients with severe hip OA, THA aims to relieve
pain partially or completely and consequently allow im-
proved function and quality of life [2]. Even considering
the risks of a surgical procedure, such as infection, the
benefits of THA, when properly indicated, have been
demonstrated [1-3,5,6,17]. In this context, patients and
professionals seek to achieve the best functional levels in
the postoperative rehabilitation period. However, aspects
of the rehabilitation of older patients should be consid-
ered [31]. The restoration of ROM and muscle strength
may be slower because of reduced muscle elasticity and
reduced ability to recruit muscle fibers [9,28].
Thus, the resources employed in physical therapy,
which have been used and investigated frequently in
adults, should be better understood when applied to
older patients. The cycle ergometer activates the muscle
groups of the hip, knee, and ankle; favors the increase
and maintenance of joint ROM of the lower limbs and
requires motor coordination for the execution of move-
ments [32]. Liebs et al. [13] evaluated the effects of cycle
ergometer-associated exercises in patients with THA
and TKA in the early postoperative period. Patients per-
formed cycle ergometer-associated exercises 3 times per
week for 3 weeks. In patients with THA, pain and func-
tion, as assessed by the WOMAC, were found to be im-
proved 3 months postoperatively in the group that
performed cycle ergometer-associated exercises com-
pared with patients who received only conventional
physical therapy. No significant improvements were ob-
served in patients with TKA.
The sessions will be supervised by the same physio-
therapist and all exercises individualized, with progres-
sion guided by the patient’s function and pain level.
Blood pressure and heart rate will be noted at the begin-
ning and end of the session as well as before, during and
after cycle ergometer-associated exercise.
Primary outcome measures include two instruments:
the HHS for functional evaluation of the hip and the
SPPB for evaluation of performance of the lower limbs.
The inclusion of the HHS was justified by its frequent
use in the local orthopedic community for functional hip
assessments in addition to its recommendations in the
literature and evidence of validity and reproducibility for
patients undergoing THA [17]. These authors emphasize
that this assessment system is the most widely used in
the evaluation of hip arthroplasty [17]. The SPPB is an
effective tool for evaluating the physical performance of
the lower limbs in the older population and has been
used in research on aging because of its high sensitivity
in identifying changes in functionality [33,34].
The secondary outcome measures used in this trial are
patient-reported outcome measures broadly applied in
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THA [8,10,12,13]. Recommendations that both generic
and specific measures be included in the assessment of
HRQOL can be found in the literature [35,36].
Some problems and limitations in conducting this trial
may interfere with its effect. First, we emphasize that the
participants in the intervention and the applicator will
not be blinded. Second, participants in the control
group, who will not perform cycle ergometer-associated
exercises, will know when reading the consent form that
this resource will not be used for their rehabilitation but
will be used by other patients with the same condition.
This may generate some disincentive; however, this fea-
ture will be offered to the control group after 10 weeks
postoperatively.
Loss to follow-up may occur over the course of the
study and may be considered a third limitation. The
study will be conducted at a regional referral hospital
where patients from neighboring cities are treated. Diffi-
culties in transporting patients to physical therapy ses-
sions can lead to missed sessions or the inability to
continue rehabilitation at this institution. In these cases,
referrals and guidance will be given for rehabilitation
services in neighboring towns and patients will return to
the study institution only for clinical follow-up.
Another consideration is that the exclusion criteria
limit the generalization of the results to other popula-
tions. Even in the case of a pilot clinical trial, the results
may not be generalized to patients with THA who are
unable to perform moderate-intensity exercise, such as
in cases of cardiovascular complications in the postoper-
ative period.
This randomized clinical trial has been designed with
the main purpose of evaluating the feasibility of under-
taking a trial to compare the effect of cycle ergometer-
associated conventional exercises to conventional exer-
cises alone in older patients with THA. The results of
the pilot trial will be used to inform the design of the fu-
ture definitive study, which would provide evidence re-
lating to the inclusion of this resource in the functional
recovery of these patients. In accordance with CON-
SORT guidelines for reporting of clinical trials, the re-
sults will be submitted to a peer-reviewed international
journal for publication irrespective of the outcome.
Trial status
The trial began in August 2011. Participant recruitment
will likely be completed after 2 years.
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